CSF3 and Absence of circulating granulocytes: Use of granulocyte colony-stimulating factor (GCSF) may reduce the duration of agranulocytosis by 4 to 5 days; in a systematic review of the use of GCSF in CLIA, Lally et al. [40] reported the mean time from starting GCSF to recovery of 7 days.